Holzer Felicitas, Roa Tania Manríquez, Germani Federico, Biller-Andorno Nikola, Luna Florencia
Dev World Bioeth. 2023 Mar;23(1):59-66. doi: 10.1111/dewb.12349. Epub 2022 Mar 20.
What has the past reaction to the COVID-19 pandemic taught us? We have seen that many low and middle-income countries (LMICs) still lack access to vaccines, and it seems little progress has been made in the last few months and year. This article discusses whether the current strategies, most notably, vaccine donations by the international community and the COVID-19 global access facility COVAX, offer meaningful solutions to tackle the problem. At the centre of our analysis, we compare the concepts of "donations" and "charity" with "vaccine equity" and the "empowerment" of poorer countries. We suggest that the achievement of fair global vaccine production requires that our global approach is supportive of the idea of empowerment. We, therefore, need structural reforms, which would most importantly include capacity building, to positively impact this goal and to take the interests of the global poor seriously.
过去对新冠疫情的应对给我们带来了哪些启示?我们已经看到,许多低收入和中等收入国家(LMICs)仍然无法获得疫苗,而且在过去几个月和一年里似乎进展甚微。本文讨论了当前的策略,最显著的是国际社会的疫苗捐赠以及新冠疫苗全球获取机制(COVAX),是否能提供有意义的解决方案来解决这一问题。在我们分析的核心,我们将“捐赠”和“慈善”的概念与“疫苗公平”以及较贫穷国家的“赋权”进行了比较。我们认为,实现公平的全球疫苗生产需要我们的全球方法支持赋权理念。因此,我们需要进行结构改革,其中最重要的是包括能力建设,以积极影响这一目标并认真对待全球贫困人口的利益。